Canopy Growth - Common Shares (CGC) closed at $0.62 on November 9, 2026, down 4.3% from the previous close, on volume of 3,278,761 shares (30-day average 2,514,033).
Data as of November 9, 2026.
9-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 28, 2026 | Diagonal Call Spread | 06-Nov-26 : 15-Jan-271 : 1.5 C | 860 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
TipRanks (Mon, 9-Nov 6:30 AM ET)
Canopy Growth Earnings Call Shows Growth and Challenges
TipRanks (Fri, 6-Nov 7:14 PM ET)
Canopy Growth Q2 topline expands 22% on international cannabis sales
Seeking Alpha News (Fri, 6-Nov 8:27 AM ET)
Canopy Growth Revenue Rises 22% as International Cannabis Sales Surge
TipRanks (Fri, 6-Nov 8:12 AM ET)
Options Volatility and Implied Earnings Moves Today, November 06, 2026
TipRanks (Fri, 6-Nov 7:05 AM ET)
Canopy Growth GAAP EPS of -C$0.10 misses by C$0.07, revenue of C$81.3M misses by C$0.75M
Seeking Alpha News (Fri, 6-Nov 7:02 AM ET)
Business Wire (Fri, 6-Nov 7:00 AM ET)
Here are the major earnings before the open Friday
Seeking Alpha News (Thu, 5-Nov 6:00 PM ET)
Canopy Growth Q2 2027 Earnings Preview
Seeking Alpha News (Thu, 5-Nov 9:18 AM ET)
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
Business Wire (Mon, 26-Oct 7:30 AM ET)
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Canopy Growth - Common Shares trades on the NASDAQ stock market under the symbol CGC.
As of November 9, 2026, CGC stock price declined to $0.62 with 3,278,761 million shares trading.
CGC has a beta of 1.41, meaning it tends to be more sensitive to market movements. CGC has a correlation of 0.08 to the broad based SPY ETF.
CGC has a market cap of $279.82 million. This is considered a Small Cap stock.
Last quarter Canopy Growth - Common Shares reported $58 million in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-971,000 and missed earnings estimates by -$.04.
In the last 3 years, CGC traded as high as $14.92 and as low as $.58.
The top ETF exchange traded funds that CGC belongs to (by Net Assets): MJ, YOLO.
CGC has underperformed the market in the last year with a price return of -42.9% while the SPY ETF gained +13.4%. CGC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -33.2% and -7.8%, respectively, while the SPY returned -1.8% and -1.0%, respectively.
CGC support price is $.62 and resistance is $.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CGC shares will trade within this expected range on the day.
